How Does the Weight of New Responsibilities on Nurses Impact Care?

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

Nurses are an integral part of the healthcare ecosystem. They have been critical to the frontline response to the pandemic, but how is the profession faring? Host Kevin Stevenson invited Kathleen O’Grady Winston, Ph.D., RN, College of Nursing Dean at the University of Phoenix, to the show to discuss what’s happening in nursing, including a new survey her college published.

The first topic Stevenson addressed was the concern of an exodus from the profession because of the stress of COVID-19. Winston shared, “There is good news on this, as 99% of respondents to our study said they are still very satisfied with the profession.”

Winston does, however, have concerns with the pipeline of qualified, eligible candidates. “We have a capacity and pipeline issues exaggerated by the pandemic but existed before,” she said.

While interest in the profession is high, Winston noted that the desire to be a nurse and what’s needed academically and personally are different things.

The curriculum for nursing is also always evolving, and COVID-19 has made its impact. “It’s a dynamic discipline, and we’ve been updating activities and experiences that prepare for the management of infectious diseases,” Winston noted.

Stevenson and Winston then went in-depth on the survey results, picking on two data points that are important to address—nurses not being heard or appreciated. How do these sentiments impact the industry?

“What they are asking for is to be at the table when decisions are made. They have a unique voice, and it’s one of advocacy for the patient. For nurses to be appreciated, transparency, sharing information, and closing the loop by communicating back to the nurses on the insight they provided,” Winston said.

Listen to Previous Episodes of MarketScale’s I Don’t Care Right Here!

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More